A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?

• Autores principales: Giacomo Aimar (Autor), Chiara Paratore (Autor), Clizia Zichi (Autor), Donatella Marino (Autor), Elisa Sperti (Autor), Andrea Caglio (Autor), Teresa Gamba (Autor), Francesca De Vita (Autor), Massimo Di Maio (Autor)
• Formato: Libro
• Publicado: Open Exploration Publishing Inc., 2021-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Patients with unresectable biliary tract carcinomas (BTCs) have a poor prognosis with a median overall survival of fewer than 12 months following systemic chemotherapy. In recent years, the identification of distinct molecular alterations with corresponding targeted therapies is modifying this thera...